The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Oral Session

Oral Session 2-9D Multiple Myeloma: Clinical (Prognosis/Biomarker/Salvage Therapy)

Sat. Oct 12, 2019 4:00 PM - 5:00 PM No.9 (Tokyo International Forum, 4F G402)

Chair: Chikako Ohwada (Department of Hematology, Chiba University Hospital)

[OS2-9D-6] Outcome of 113 myeloma patients who received triplet induction treatment followed by up-front ASCT

Nobuhiro Tsukada, Junichiro Nashimoto, Yui Uto, Kota Sato, Kanji Miyazaki, Mizuki Ogura, Yumiko Yoshiki, Yu Abe, Kiyoshi Okazuka, Tadao Ishida, Kenshi Suzuki (Dept. of Hematol., Japanese Red Cross Medical Center, Tokyo, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password